The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Anxiety disorders and GABA neurotransmission: a disturbance of modulation
Open accessAbstract
Lines of evidence coming from many branches of neuroscience indicate that anxiety disorders arise from a dysfunction in the modulation of brain circuits which regulate emotional responses to potentially threatening stimuli. The concept of anxiety disorders as a disturbance of emotional response regulation is a useful one as it allows anxiety to be explained in terms of a more general model of aberrant salience and also because it identifies avenues for developing psychological, behavioral, and pharmacological strategies for the treatment of anxiety disorder. These circuits involve bottom-up activity from the amygdala, indicating the presence of potentially threatening stimuli, and top-down control mechanisms originating in the prefrontal cortex, signaling the emotional salience of stimuli. Understanding the factors that control cortical mechanisms may open the way to identification of more effective cognitive behavioral strategies for managing anxiety disorders. The brain circuits in the amygdala are thought to comprise inhibitory networks of γ-aminobutyric acid-ergic (GABAergic) interneurons and this neurotransmitter thus plays a key role in the modulation of anxiety responses both in the normal and pathological state. The presence of allosteric sites on the GABAA receptor allows the level of inhibition of neurons in the amygdala to be regulated with exquisite precision, and these sites are the molecular targets of the principal classes of anxiolytic drugs. Changes in the levels of endogenous modulators of these allosteric sites as well as changes in the subunit composition of the GABAA receptor may represent mechanisms whereby the level of neuronal inhibition is downregulated in pathological anxiety states. Neurosteroids are synthesized in the brain and act as allosteric modulators of the GABAA receptor. Since their synthesis is itself regulated by stress and by anxiogenic stimuli, targeting the neurosteroid-GABAA receptor axis represents an attractive target for the modulation of anxiety.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
The cognitive control of emotion
OCHSNER, K., & GROSS, J. (2005) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2005.03.010 · Cited by 4,495
Functional neuroanatomy of emotion: A meta-analysis of emotion activation studies in PET and fMRI
Phan, K. L., Wager, T., Taylor, S. F., & Liberzon, I. (2002) · NeuroImage · doi:10.1006/nimg.2002.1087 · Cited by 3,502
Etkin, A., & Wager, T. D. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07030504 · Cited by 3,391 · cited 1×
“Moreover, patients with anxiety disorders appear to activate the amygdala in response to a given stimulus more than non-anxious controls.(20) In addition, successful treatment of anxiety disorders with cognitive behavioral therapy leads to extinction of this hyperactivation of the amygdala.”
BackgroundThe empirical status of cognitive-behavioral therapy: A review of meta-analyses
Butler, A. C., Chapman, J. E., Forman, E. M., & Beck, A. T. (2006) · Clinical Psychology Review · doi:10.1016/j.cpr.2005.07.003 · Cited by 3,215
Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors
Farrant, M., & Nusser, Z. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1625 · Cited by 2,081
Neuronal Diversity and Temporal Dynamics: The Unity of Hippocampal Circuit Operations
Klausberger, T., & Somogyi, P. (2008) · Science · doi:10.1126/science.1149381 · Cited by 2,050
Rauch, S. L., Shin, L. M., & Phelps, E. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.004 · Cited by 1,397 · cited 1×
“Again, neuroimaging studies have shown the medial PFC to be hypoactive in certain anxiety disorders, notably posttraumatic stress disorder 20,30 and generalized anxiety disorder.”
Wager, T. D., Phan, K. L., Liberzon, I., & Taylor, S. F. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00078-8 · Cited by 1,150
Kober, H., Barrett, L. F., Joseph, J., Bliss-Moreau, E., Lindquist, K., & Wager, T. D. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.03.059 · Cited by 1,144 · cited 1×
“and are activated concomitantly with the amygdala during presentation of emotional stimuli.(26)”
BackgroundPitkänen, A., Savander, V., & LeDoux, J. E. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01125-9 · Cited by 980
Neumann, I. D., & Landgraf, R. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.08.004 · Cited by 954
Purdy, R. H., Morrow, A. L., Moore, P. H., & Paul, S. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4553 · Cited by 951
Molecular and neuronal substrate for the selective attenuation of anxiety
Löw, K., Crestani, F., Keist, R., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Rülicke, T., Bluethmann, H., Möhler, H., et al. (2000) · Science · doi:10.1126/science.290.5489.131 · Cited by 946
Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., & Schumacher, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3295 · Cited by 930
Subunit Composition, Distribution and Function of GABA-A Receptor Subtypes
Sieghart, W., & Sperk, G. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026023393507 · Cited by 914
Kim, M. J., Loucks, R. A., Palmer, A. L., Brown, A. C., Solomon, K. M., Marchante, A. N., & Whalen, P. J. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.04.025 · Cited by 838
Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites
Hosie, A. M., Wilkins, M. E., da Silva, H. M. A., & Smart, T. G. (2006) · Nature · doi:10.1038/nature05324 · Cited by 752
Recognition of facial emotion in nine individuals with bilateral amygdala damage
Adolphs, R., Tranel, D., Hamann, S., Young, A. W., Calder, A. J., Phelps, E. A., Anderson, A., Lee, G. P., & Damasio, A. R. (1999) · Neuropsychologia · doi:10.1016/s0028-3932(99)00039-1 · Cited by 740
McDonald, A. J., Mascagni, F., & Guo, L. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00417-3 · Cited by 689
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676
(2010) · Progress in Brain Research · doi:10.1016/b978-0-444-53630-3.00008-7 · Cited by 584
Benzodiazepines revisited—will we ever learn?
Lader, M. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03563.x · Cited by 573
Neurosteroids: biochemistry and clinical significance
Mellon, S. H., & Griffin, L. D. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00503-3 · Cited by 538
The role of GABA in anxiety disorders.
Lydiard, R. B. (2003) · PubMed · Cited by 535
Diversity of inhibitory neurotransmission through GABAA receptors
Mody, I., & Pearce, R. A. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.07.002 · Cited by 525
Bottom-Up and Top-Down Processes in Emotion Generation: Common and Distinct Neural Mechanisms
Ochsner, K. N., Ray, R. R., Hughes, B., McRae, K., Cooper, J. C., Weber, J., Gabrieli, J. D. E., & Gross, J. J. (2009) · Psychological Science · doi:10.1111/j.1467-9280.2009.02459.x · Cited by 523
Neurosteroid modulation of GABAA receptors
Lambert, J. J., Belelli, D., Peden, D. R., Vardy, A. W., & Peters, J. A. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.09.001 · Cited by 493
Petrovic, P., Dietrich, T., Fransson, P., Andersson, J., Carlsson, K., & Ingvar, M. (2005) · Neuron · doi:10.1016/j.neuron.2005.05.023 · Cited by 437 · cited 2×
“The strength of the activation of the anterior cingulate cortex was strongly correlated with the robustness of the placebo effect.(33) Understanding how these cortical–subcortical regulatory mechanisms work and how they can be harnessed could be very important in developing more effective interventions to reduce anxie…”
BackgroundQuaternary Structure of the Native GABAA Receptor Determined by Electron Microscopic Image Analysis
Nayeem, N., Green, T. P., Martin, I. L., & Barnard, E. A. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62020815.x · Cited by 437
Bandelow, B., Sher, L., Bunevicius, R., Hollander, E., Kasper, S., Zohar, J., Möller, H.-J., WFSBP Task Force on Mental Disorders in Primary Care, & WFSBP Task Force on Anxiety Disorders, O. A. P. (2012) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2012.667114 · Cited by 428
Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties
Rupprecht, R. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00064-1 · Cited by 427
Paul, S. M., & Purdy, R. H. (1992) · PubMed · Cited by 384
An Inhibitory Interface Gates Impulse Traffic between the Input and Output Stations of the Amygdala
Royer, S., Martina, M., & Paré, D. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-23-10575.1999 · Cited by 354
A Specialized Subclass of Interneurons Mediates Dopaminergic Facilitation of Amygdala Function
Marowsky, A., Yanagawa, Y., Obata, K., & Vogt, K. E. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.029 · Cited by 328
Regulation of anxiety by GABAA receptors in the rat amygdala
Sanders, S. K., & Shekhar, A. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00153-n · Cited by 317
Structure, Pharmacology, and Function of GABAA Receptor Subtypes
Sieghart, W. (2006) · Advances in Pharmacology · doi:10.1016/s1054-3589(06)54010-4 · Cited by 317
Paulus, M. P., Feinstein, J. S., Castillo, G., Simmons, A. N., & Stein, M. B. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.3.282 · Cited by 314
Emotion Induction After Direct Intracerebral Stimulations of Human Amygdala
Lanteaume, L., Khalfa, S., Regis, J., Marquis, P., Chauvel, P., & Bartolomei, F. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhl041 · Cited by 312
Localizing 3H-GABA in Nerve Terminals of Rat Cerebral Cortex by Electron Microscopic Autoradiography
BLOOM, F. E., & IVERSEN, L. L. (1971) · Nature · doi:10.1038/229628a0 · Cited by 307
Patchev, V. K., Shoaib, M., Holsboer, F., & Almeida, O. F. X. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90330-1 · Cited by 306
Anxiety Reduction through Detachment: Subjective, Physiological, and Neural Effects
Kalisch, R., Wiech, K., Critchley, H. D., Seymour, B., O'Doherty, J. P., Oakley, D. A., Allen, P., & Dolan, R. J. (2005) · Journal of Cognitive Neuroscience · doi:10.1162/0898929054021184 · Cited by 303
Progesterone selectively increases amygdala reactivity in women
van Wingen, G. A., van Broekhoven, F., Verkes, R. J., Petersson, K. M., Bäckström, T., Buitelaar, J. K., & Fernández, G. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002030 · Cited by 273
Effects of cognitive-behavioral therapy on brain activation in specific phobia
Straube, T., Glauer, M., Dilger, S., Mentzel, H.-J., & Miltner, W. H. R. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2005.07.007 · Cited by 266
Grillon, C., Morgan, C. A., Davis, M., & Southwick, S. M. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00034-1 · Cited by 263
Role of kappa-opioid receptors in stress and anxiety-related behavior
Van’t Veer, A., & Carlezon, W. A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3195-5 · Cited by 257
The endocannabinoid system in anxiety, fear memory and habituation
Ruehle, S., Rey, A. A., Remmers, F., & Lutz, B. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111408958 · Cited by 235
The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABAA receptors
Brot, M. D., Akwa, Y., Purdy, R. H., Koob, G. F., & Britton, K. T. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00096-4 · Cited by 234
Stress and neuroactive steroids
Barbaccia, M. L., Serra, M., Purdy, R. H., & Biggio, G. (2001) · International Review of Neurobiology · doi:10.1016/s0074-7742(01)46065-x · Cited by 233
Functional neuroanatomy of anxiety: a neural circuit perspective
Etkin, A. (2009) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2009_5 · Cited by 227
The role of GABAergic neuroactive steroids in ethanol action, tolerance and dependence
Morrow, A. L., VanDoren, M. J., Penland, S. N., & Matthews, D. B. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00127-8 · Cited by 222
Biosynthesis of neurosteroids and regulation of their sysnthesis
Mellon, S. H., & Vaudry, H. (2001) · International Review of Neurobiology · doi:10.1016/s0074-7742(01)46058-2 · Cited by 215
Neurosteroids and GABA-A Receptor Function
Wang, M. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00044 · Cited by 195
The Serotonergic System and Anxiety
Gordon, J. A., & Hen, R. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:1:027 · Cited by 194
Feeling anxious: anticipatory amygdalo-insular response predicts the feeling of anxious anticipation
Carlson, J. M., Greenberg, T., Rubin, D., & Mujica-Parodi, L. R. (2011) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsq017 · Cited by 170
Clinical practice guidelines. Management of anxiety disorders.
(2006) · PubMed · Cited by 167
Central functions of neuropeptide Y in mood and anxiety disorders
Wu, G., Feder, A., Wegener, G., Bailey, C., Saxena, S., Charney, D., & Mathé, A. A. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.628314 · Cited by 163
Functioning of neural systems supporting emotion regulation in anxiety-prone individuals
Campbell‐Sills, L., Simmons, A. N., Lovero, K. L., Rochlin, A., Paulus, M. P., & Stein, M. B. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.07.041 · Cited by 160
The Endocannabinoid System and the Treatment of Mood and Anxiety Disorders
Hill, M. N., & Gorzalka, B. B. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824624 · Cited by 159
Nguyễn, N. T., Fakra, É., Pradel, V., Jouve, É., Alquier, C., Guern, M. L., Micallef, J., & Blin, O. (2006) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.757 · Cited by 156
Pinna, G., Costa, E., & Guidotti, A. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.12.006 · Cited by 156
Emotionality and interference with color-naming in anxiety
Mathews, A., & Klug, F. (1993) · Behaviour Research and Therapy · doi:10.1016/0005-7967(93)90043-t · Cited by 155
Protein mobility and GABA-induced conformational changes in GABAA receptor pore-lining M2 segment
Horenstein, J., Wagner, D. A., Czajkowski, C., & Akabas, M. H. (2001) · Nature Neuroscience · doi:10.1038/87425 · Cited by 154
Verleye, M., Akwa, Y., Lière, P., Ladurelle, N., Pianos, A., Eychenne, B., Schumacher, M., & Gillardin, J. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.11.013 · Cited by 148
Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?
Schüle, C., Eser, D., Baghai, T. C., Nothdurfter, C., Kessler, J. S., & Rupprecht, R. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.025 · Cited by 147
Testosterone Increases Amygdala Reactivity in Middle-Aged Women to a Young Adulthood Level
van Wingen, G. A., Zylicz, S. A., Pieters, S., Mattern, C., Verkes, R. J., Buitelaar, J. K., & Fernández, G. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.2 · Cited by 147
Individual Properties of the Two Functional Agonist Sites in GABAAReceptors
Baumann, S. W., Baur, R., & Sigel, E. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11158.2003 · Cited by 146
Different Fear States Engage Distinct Networks within the Intercalated Cell Clusters of the Amygdala
Busti, D., Geracitano, R., Whittle, N., Dalezios, Y., Mańko, M., Kaufmann, W. A., Sätzler, K., Singewald, N., Capogna, M., & Ferraguti, F. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6100-10.2011 · Cited by 138
Administration of progesterone produces mild sedative-like effects in men and women
Gordh, A. S., Lindsey, S., Purdy, R. H., Hauger, R., & de Wit, H. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00033-7 · Cited by 132
Patchev, V. K., Montkowski, A., Rouskova, D., Korányi, L., Holsboer, F., & Almeida, O. F. X. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119261 · Cited by 121
Modulation of GABAergic synaptic transmission by the non-benzodiazepine anxiolytic etifoxine
Schlichter, R., Rybalchenko, V., Poisbeau, P., Verleye, M., & Gillardin, J. M. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00253-1 · Cited by 121
Brain neurosteroids during the mouse oestrous cycle
Corpechot, C., Collins, B., Carey, M. P., Tsouros, A. E., Röbel, P., & Fry, J. P. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00749-x · Cited by 118
3α-reduced neuroactive steroids and their precursors during pregnancy and the postpartum period
Evans, S. E. G., Ross, L. E., Sellers, E. M., Purdy, R. H., & Romach, M. K. (2005) · Gynecological Endocrinology · doi:10.1080/09513590500361747 · Cited by 118
Frye, C. A., & Scalise, T. J. (2000) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(99)00068-2 · Cited by 114
Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety
Thorsell, A. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.009331 · Cited by 109
A Closer Look at the High Affinity Benzodiazepine Binding Site on GABAA Receptors
Sigel, E., & Lüscher, B. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611794863562 · Cited by 106
Cagetti, E., Pinna, G., Guidotti, A., Baicy, K., & Olsen, R. W. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.10.001 · Cited by 103
GABAA-receptor Subtypes: Clinical Efficacy and Selectivity of Benzodiazepine Site Ligands
Korpi, E. R., Mattila, M. J., Wisden, W., & Lüddens, H. (1997) · Annals of Medicine · doi:10.3109/07853899708999348 · Cited by 91
Toufexis, D. J., Davis, C., Hammond, A., & Davis, M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1386-04.2004 · Cited by 86
The modulatory effects of the anxiolytic etifoxine on GABAA receptors are mediated by the β subunit
Hamon, A., Morel, A., Hue, B., Verleye, M., & Gillardin, J. M. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00187-4 · Cited by 80
Pinto, A., & Sesack, S. R. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0180-6 · Cited by 77
Heldt, S. A., Mou, L., & Ressler, K. J. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.101 · Cited by 76
Durant, C. F., Christmas, D. M., & Nutt, D. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_8 · Cited by 75
Nothdurfter, C., Rammes, G., Baghai, T. C., Schüle, C., Schumacher, M., Papadopoulos, V., & Rupprecht, R. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02166.x · Cited by 75
Pathirathna, S., Todorovic, S. M., Covey, D. F., & Jevtović‐Todorović, V. (2005) · Pain · doi:10.1016/j.pain.2005.06.019 · Cited by 73
Neuroactive Steroid Levels in Patients With Generalized Anxiety Disorder
Semeniuk, T., Jhangri, G. S., & Mellédo, J. L. (2001) · Journal of Neuropsychiatry · doi:10.1176/jnp.13.3.396 · Cited by 72
Low pregnenolone sulphate plasma concentrations in patients with generalized social phobia
Heydari, B., & Mellédo, J. L. (2002) · Psychological Medicine · doi:10.1017/s0033291702005238 · Cited by 69
Histories of depression, allopregnanolone responses to stress, and premenstrual symptoms in women
Klatzkin, R. R., Morrow, A. L., Light, K. C., Pedersen, C. A., & Girdler, S. S. (2005) · Biological Psychology · doi:10.1016/j.biopsycho.2005.02.007 · Cited by 66
Jongen‐Rêlo, A. L., & Amaral, D. G. (1998) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1998.00299.x · Cited by 65
Micallef, J., Soubrouillard, C., Guet, F., Guern, M. E. L., Alquier, C., Bruguerolle, B., & Blin, O. (2001) · Fundamental and Clinical Pharmacology · doi:10.1046/j.1472-8206.2001.00025.x · Cited by 65
Functional connectivity of the main intercalated nucleus of the mouse amygdala
Mańko, M., Geracitano, R., & Capogna, M. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2010.201475 · Cited by 60
Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders
Nothdurfter, C., Baghai, T. C., Schüle, C., & Rupprecht, R. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0352-5 · Cited by 60
Effects of diazepam on BOLD activation during the processing of aversive faces
Del‐Ben, C. M., Ferreira, C. A., Sanchez, T. A., Alves-Neto, W. C., Guapo, V. G., de Araújo, D. B., & Graeff, F. G. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110389092 · Cited by 60
Palomares-Castillo, E., Hernández‐Pérez, O. R., Pérez-Carrera, D., Crespo‐Ramírez, M., Fuxé, K., & de la Mora, M. P. (2012) · Brain Research · doi:10.1016/j.brainres.2012.03.047 · Cited by 57
Servant, D., Graziani, P., Moyse, D., & Parquet, P. J. (1998) · PubMed · Cited by 55
Neuroactive Steroids as Endogenous Modulators of Anxiety
Eser, D., Baghai, T. C., Schüle, C., Nothdurfter, C., & Rupprecht, R. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786848838 · Cited by 53
Aouad, M., Charlet, A., Rodeau, J., & Poisbeau, P. (2009) · Pain · doi:10.1016/j.pain.2009.08.001 · Cited by 52
Historical Perspective and Emergence of the GABAB Receptor
Bowery, N. G. (2010) · Advances in pharmacology · doi:10.1016/s1054-3589(10)58001-3 · Cited by 51
Neurosteroid allopregnanolone mediates anxiolytic effect of etifoxine in rats
Ugale, R. R., Sharma, A. N., Kokare, D. M., Hirani, K., Subhedar, N. K., & Chopde, C. T. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.041 · Cited by 50
The Role of the Amygdala in Anxiety Disorders
Gina, L., Andrew, M., Jamie, L. A., & Michael, J. (2012) · InTech eBooks · doi:10.5772/50323 · Cited by 49
Plasma concentrations of anxiolytic neuroactive steroids in men with panic disorder
Brambilla, F., Mellado, C., Alciati, A., Pisu, M. G., Purdy, R. H., Zanone, S., Perini, G., Serra, M., & Biggio, G. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2004.11.009 · Cited by 48
Barbalho, C. A., Nunes‐de‐Souza, R. L., & Canto‐de‐Souza, A. (2009) · Brain Research · doi:10.1016/j.brainres.2009.02.042 · Cited by 47
Eser, D., di Michele, F., Zwanzger, P., Pasini, A., Baghai, T. C., Schüle, C., Rupprecht, R., & Romeo, E. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300572 · Cited by 45
Royer, S., Martina, M., & Paré, D. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09034.2000 · Cited by 44
Is Baclofen a Revolutionary Medication in Alcohol Addiction Management? Review and Recent Updates
Gorsane, M.-A., Kébir, O., Hache, G., Blecha, L., Aubin, H., Reynaud, M., & Benyamina, A. (2012) · Substance Abuse · doi:10.1080/08897077.2012.663326 · Cited by 39
Rowlett, J. K., Winger, G. D., Carter, R. B., Wood, P. L., Woods, J. H., & Woolverton, W. L. (1999) · Psychopharmacology · doi:10.1007/s002130051050 · Cited by 36
Panic disorder, agoraphobia, and anxiety-relevant cognitive style
Ganellen, R. J., Matuzas, W., UHLENHUTH, E. H., Glass, R. M., & Easton, C. R. (1986) · Journal of Affective Disorders · doi:10.1016/0165-0327(86)90073-x · Cited by 36
Chronic pregnenolone effects in normal humans: attenuation of benzodiazepine-induced sedation
Meieran, S. E., Reus, V. I., Webster, R., Shafton, R., & Wolkowitz, O. M. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00056-8 · Cited by 34
Maayan, R., Noy‐Lotan, S., Doron, R., Shabat-Simon, M., Gispan-Herman, I., Weizman, A., & Yadid, G. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.10.002 · Cited by 30
A general anxiety-prone cognitive style in anxiety disorders
UHLENHUTH, E. H., Starčević, V., Warner, T. D., Matuzas, W., McCarty, T. A., Roberts, B., & Jenkusky, S. M. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00457-8 · Cited by 21
Etifoxine promotes glial-derived neurotrophic factor-induced neurite outgrowth in PC12 cells
Zhou, X., HE, X., He, B., Zhu, Z., Zheng, C., Xu, J., Jiang, L., Gu, L., Zhu, J., Zhu, Q., et al. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1474 · Cited by 21
Pathophysiological aspects of diversity in neuronal inhibition: a new benzodiazepine pharmacology
Möhler, H. (2002) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2002.4.3/hmoehler · Cited by 16
Nonpharmacological treatments for anxiety disorders
Cottraux, J. A. (2002) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2002.4.3/jcottraux · Cited by 16
Verleye, M., Heulard, I., & Gillardin, J. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1066-7 · Cited by 14
Can levels of a general anxiety-prone cognitive style distinguish between various anxiety disorders?
Starčević, V., Sammut, P., Berle, D., Hannan, A., Milicevic, D., Moses, K., Lamplugh, C., & Eslick, G. D. (2011) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2011.08.004 · Cited by 3
Cited by
Hippocampal GABAergic Inhibitory Interneurons
Pelkey, K. A., Chittajallu, R., Craig, M. T., Tricoire, L., Wester, J. C., & McBain, C. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00007.2017 · Cited by 889
Understanding Emotions: Origins and Roles of the Amygdala
Šimić, G., Tkalčić, M., Vukić, V., Mulc, D., Španić, E., Šagud, M., Olucha-Bordonau, F. E., Vukšić, M., & R. Hof, P. (2021) · Biomolecules · doi:10.3390/biom11060823 · Cited by 503
An Updated Review on Pharmaceutical Properties of Gamma-Aminobutyric Acid
Ngo, D.-H., & Vo, T. S. (2019) · Molecules · doi:10.3390/molecules24152678 · Cited by 403
Inhibition in the amygdala anxiety circuitry
Babaev, O., Piletti Chatain, C., & Krueger-Burg, D. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0063-8 · Cited by 308
Emerging Modalities and Implantable Technologies for Neuromodulation
Won, S. M., Song, E., Reeder, J. T., & Rogers, J. A. (2020) · Cell · doi:10.1016/j.cell.2020.02.054 · Cited by 291
Metadata
- Authors
- Gauthier, I., & Nuss, P.
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2015-01
- Volume
- 11
- Pages
- 165
- ISSN
- 1176-6328 (ISSN-L)
- 1178-2021
- OpenAlex
- W2071967920
- Cited by
- 466
- References
- 115
- FWCI
- 13.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.